Book contents
- Frontmatter
- Contents
- List of Figures
- List of Tables
- List of Contributors
- Introduction
- PART I ADVANCES IN GPCR PROTEIN RESEARCH
- PART II OLIGOMERIZATION OF GPCRS
- PART III GPCR SIGNALING FEATURES
- PART IV LIGAND PHARMACOLOGY OF GPCRS
- PART V PHYSIOLOGICAL FUNCTIONS AND DRUG TARGETING OF GPCRS
- 15 β-Adrenoceptors in cardiovascular and respiratory diseases
- 16 Role of metabotropic glutamate receptors in CNS disorders
- 17 S1P receptor agonists, a novel generation of immunosuppressants
- 18 Wnt/Frizzled receptor signaling in osteoporosis
- Index
- References
17 - S1P receptor agonists, a novel generation of immunosuppressants
from PART V - PHYSIOLOGICAL FUNCTIONS AND DRUG TARGETING OF GPCRS
Published online by Cambridge University Press: 05 June 2012
Book contents
- Frontmatter
- Contents
- List of Figures
- List of Tables
- List of Contributors
- Introduction
- PART I ADVANCES IN GPCR PROTEIN RESEARCH
- PART II OLIGOMERIZATION OF GPCRS
- PART III GPCR SIGNALING FEATURES
- PART IV LIGAND PHARMACOLOGY OF GPCRS
- PART V PHYSIOLOGICAL FUNCTIONS AND DRUG TARGETING OF GPCRS
- 15 β-Adrenoceptors in cardiovascular and respiratory diseases
- 16 Role of metabotropic glutamate receptors in CNS disorders
- 17 S1P receptor agonists, a novel generation of immunosuppressants
- 18 Wnt/Frizzled receptor signaling in osteoporosis
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- G Protein-Coupled ReceptorsStructure, Signaling, and Physiology, pp. 380 - 397Publisher: Cambridge University PressPrint publication year: 2010
References
et al. (2000) Sphingosine 1-phosphate signalling in mammalian cells. Biochem J, 349 (2), 385–402.CrossRefGoogle ScholarPubMed
et al. (2000) Human sphingosine kinase: Purification, molecular cloning and characterization of the native and recombinant enzymes. Biochemistry Journal, 350 (2), 429–441.CrossRefGoogle ScholarPubMed
et al. (1998) Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biophys. Res. Commun. 242, 502–507.CrossRefGoogle ScholarPubMed
et al. (1996) Supression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381, 800–803.CrossRefGoogle Scholar
et al. (2007) Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol. Metab., 18¸300–307.CrossRefGoogle ScholarPubMed
et al. (2005) Sphk1 and Sphk2: Sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem., 280, 37118–37129.CrossRefGoogle ScholarPubMed
et al. (2007) Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2. J. Biol. Chem. 282, 3472–3480.CrossRefGoogle ScholarPubMed
et al. (2005) Essential role for sphingosine kinases in neural and vascular development. Mol. Cell Biol., 25, 11113–11121.CrossRefGoogle ScholarPubMed
et al. (2000) An oncogenic role of sphingosine kinase. Curr. Biol. 10, 1527–1530.CrossRefGoogle ScholarPubMed
et al (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science, 316, 295–298.CrossRefGoogle ScholarPubMed
(2002) Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?Biochim. Biophys. Acta, 1582, 132–137.CrossRefGoogle ScholarPubMed
et al. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121, 969–973.CrossRefGoogle ScholarPubMed
et al. (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J., 21, 1202–1209.CrossRefGoogle ScholarPubMed
et al. (2008) Production and release of sphingosine-1-phosphate and the phosphorylated form of the immunomodulator FTY720. Biochim. Biophys. Acta, 1781, 496–502.CrossRefGoogle ScholarPubMed
et al. (2008) Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ. Res., 102, 669–676.CrossRefGoogle Scholar
et al. (2006) IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem., 281, 2515–2525.CrossRefGoogle ScholarPubMed
et al. (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl. Acad. Sci. U.S.A., 103, 16394–16399.CrossRefGoogle ScholarPubMed
, et al. (2006) Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J. Lipid Res., 47, 614–621.CrossRefGoogle Scholar
et al. (2007) A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). ProstaglandinsOther Lipid Mediat., 84, 154–162.CrossRefGoogle Scholar
et al (2000) Neutral/alkaline and acid ceramidase activities are activily released by murine endothelial cells. Biochem. Biophys. Res. Commun., 275, 476–751.CrossRefGoogle Scholar
, , , , , , , , (2002) Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem., 277, 6667–6675.CrossRefGoogle ScholarPubMed
et al. (1998) Dual actions of sphingosine-1-phosphate: extracellular through the Gi- coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol., 142(1), 229–240.CrossRefGoogle ScholarPubMed
et al. (2005) Products by the sphingosine kinase/sphingosine-1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis. Genes Cells, 10 (6), 605–615.CrossRefGoogle Scholar
et al. (1990) An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265, 9308–9313.Google ScholarPubMed
et al. (1998) EDG1 is a functional sphingosine-1-phosphate receptor that is linged via a Gi/o to multiple signalling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J. Biol. Chem. 273, 27104–27110.CrossRefGoogle Scholar
et al. (2001) Tethering of the platelet-derived growth factor beta receptor to G-protein coupled receptors: a novel platform for integrative signalling by these receptor classes in mammalian cells. J. Biol. Chem. 276, 28578–28585.CrossRefGoogle Scholar
et al.(2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951–961.CrossRefGoogle Scholar
et al. (2003) G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102, 3665–3667.CrossRefGoogle ScholarPubMed
et al. (2004) Expression of the sphingosine-1-phosphate receptor, S1P1, on T cells controls thymic emigration. J. Biol. Chem. 279 (15), 15396–15401.CrossRefGoogle Scholar
et al. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (6972), 355–360.CrossRefGoogle ScholarPubMed
et al. (2005) Cutting edge: Regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1. J. Immunol. 174 (5), 2485–2488.CrossRefGoogle ScholarPubMed
et al. (2006) Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203(12), 2683–2690.CrossRefGoogle ScholarPubMed
et al. (2005), Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J. Oct; 19 (12):1646–56.CrossRefGoogle ScholarPubMed
et al (2007) Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells 25, 115–124.CrossRefGoogle Scholar
et al. (2001) Selective loss of sphingosine 1-phosphate signalling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP (B3)/EDG-3. J. Biol. Chem. 276, 33697–33704.CrossRefGoogle Scholar
et al.(1999) Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J. Biol. Chem. 274, 18997–19002.CrossRefGoogle ScholarPubMed
et al. (2000) Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol. Cell. Biol. 20, 9247–9261.CrossRefGoogle ScholarPubMed
et al. (2001) Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J. Biol. Chem. 276, 11830–11837.CrossRefGoogle ScholarPubMed
et al. (2005) The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol. Cell. Biol. 25(10), 4237–4249.CrossRefGoogle ScholarPubMed
et al. (2004) S1P3-mediated Akt-activation and cross-talk with platelet-derived growth factor receptor (PDGFR). FASEB J. 18(2), 341–343.CrossRefGoogle Scholar
et al. (2002) Marked perinatal lethality and cellular signalling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J. Biol. Chem. 277, 25152–25159.CrossRefGoogle Scholar
et al.(2004) The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function co-ordinately during embryonic angiogenesis. J. Biol. Chem. 279, 29367–29373.CrossRefGoogle Scholar
et al. (2001) An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur. J. Neurosci. 14, 203–209.CrossRefGoogle ScholarPubMed
et al. (2007) The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB J. 21, 2005–2013.CrossRefGoogle ScholarPubMed
et al. (2006) Lentiviral siRNA silencing of sphingosine-1-phosphate receptors S1P1 and S1P2 in smooth muscle. Biochem. Biophys. Res. Commun. 343, 1038–1044.CrossRefGoogle ScholarPubMed
et al. (2004) Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279, 13839–13848.CrossRefGoogle ScholarPubMed
et al. (2006) High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114, 1403–1409.CrossRefGoogle ScholarPubMed
et al. (2005) S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc. Natl. Acad. Sci. U.S.A. 102, 9270–9275.CrossRefGoogle ScholarPubMed
et al. (2008) Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452, 654–658.CrossRefGoogle ScholarPubMed
et al. (2003) The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J. Cell. Biochem. 89, 507–519.CrossRefGoogle ScholarPubMed
et al. (2001) Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors. J. Biol. Chem. 276: 5692–5699.CrossRefGoogle ScholarPubMed
. 2005: http://www.informatics.jax.org/external/ko/deltagen/302
et al. (2005) Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J. Neurosci. 25, 1459–1469.CrossRefGoogle ScholarPubMed
et al. (2007) Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J. 21, 1503–1514.CrossRefGoogle ScholarPubMed
et al. (2007) Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol. 8, 1337–1344.CrossRefGoogle ScholarPubMed
et al. (2008) The alliance of sphingosine 1-phospahte and its receptors in immunity. Nat. Rev. Immunol. 8, 753–763.CrossRefGoogle Scholar
(2007) Specifying the patterns of immune cell migrationNovartis Found. Symp. 281; 54–61CrossRefGoogle ScholarPubMed
et al. (2009) Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nat Immunol.; 10 (1):58–65.CrossRefGoogle ScholarPubMed
, and (1991) A pertussis toxin-sensitive process controls thymocyte emigration. Eur J Immunol.; 21(10):2565–73.CrossRefGoogle ScholarPubMed
, et al. (2006) Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. Cell Mol. Immunol. 3 (1):11–9Google ScholarPubMed
et al (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science; 296 (5566):346–9.CrossRefGoogle Scholar
et al. (2008) The vascular S1P gradient: cellular sources and biological significance. Biochim Biophys Acta; 1781(9):477–82.CrossRefGoogle ScholarPubMed
et al. (2006) Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor. Bioorg Med Chem Lett. ;16(14):3684–7.CrossRefGoogle ScholarPubMed
and (2007) Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol. 8 (12):1295–301CrossRefGoogle ScholarPubMed
, et al. (2009) Sphingosine 1-phosphate receptor signaling. Annu Rev Biochem; 78:743–68.CrossRefGoogle ScholarPubMed
, et al. (2005) Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol. 6 (12):1228–35.CrossRefGoogle ScholarPubMed
et al. (2006) Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol. 2 (8):434–41.CrossRefGoogle ScholarPubMed
et al. (2007) Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem.; 282 (12):9082–9.CrossRefGoogle ScholarPubMed
et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123–1132.CrossRefGoogle Scholar
et al. (2007) Cutting edge: alternative signalling of Th17 cell development by sphingosine 21-phosphate. J.Immunol. 178, 5425–5428.CrossRefGoogle Scholar
et al. (2007) Th17 augmentation in OTII TCR plus T cell-selective type 1 sphingosine 1-phosphate receptor double transgenic mice. J. Immunol. 178, 6806–6813.CrossRefGoogle Scholar
et al. (2008) CD4+ Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas. Curr. Opin. Immunol. 20, 655–662.CrossRefGoogle ScholarPubMed
et al. (2009) The receptor SP1 overrides regulatory T cell mediated immune suppression through Akt-mTOR. Nat. Immunol. Jul;10 (7):769–77.CrossRefGoogle Scholar
et al. (2008) New players on the center stage: Sphingosine 1-phosphate and its receptors as drug targets. Biochem.Pharmacol. 75: 1893–1900.CrossRefGoogle ScholarPubMed
et al. (2007) FTY720, an immunomodulatory sphingolipd mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis. Expert Opin. Investig.Drugs 16; 283–289CrossRefGoogle Scholar
et al. (2007) Current perspectives on FTY720. Expert Opin. Invest. Drugs 16, 505–518.CrossRefGoogle ScholarPubMed
et al. (2009) Oral fingolimod (FTY720) in multiple sclerosis, Two year results of a phase II extension study. Neurology 72, 73–79.CrossRefGoogle Scholar
et al. (2005) The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J Immunol; 175 (12):7973–80.CrossRefGoogle ScholarPubMed
et al. (2009) Phase I study with the selective S1P1/S1P5 receptor modulator BAF312 indicates that S1P1 rather than S1P3 mediates transient heart rate reduction in humans. Abstract P437. 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Sep 9–12, Düsseldorf, Germany.
et al. (2008) Targeting SphK1 as a new strategy against cancer. Curr Drug Targets. ;9(8):662–73.CrossRefGoogle ScholarPubMed
et al. (2008) LX2931: A Potential Small Molecule Treatment for Autoimmune Disorders. Presentation # 351, American College of Rheumatology meeting.
et al. (2009) Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. J. Lipid Res. 50, 2245–2257.CrossRefGoogle Scholar
et al. (2007) The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 607–613.CrossRefGoogle ScholarPubMed
et al. (2006) Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest. 116, 2935–2944.CrossRefGoogle ScholarPubMed
et al. (2008) Sphingosine-1-phosphate and its analogue FTY720 diminish acute pulmonary injury in rats with acute necrotizing pancreatitis. Pancreas 36, e10–5.CrossRefGoogle ScholarPubMed
, et al. (2006). Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation. Transplantation 82, 804–812.CrossRefGoogle ScholarPubMed
et al. (2008) Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist. Kidney Int. 74, 1319–1326.CrossRefGoogle ScholarPubMed
et al. (2007) A novel sphingosine-1-phosphate receptor agonist KRP-203 attenuates rat autoimmune myocarditis. Biochem. Biophys. Res. Commun. 361, 621–628.CrossRefGoogle ScholarPubMed
, et al. (2007) Sphingosine 1-phosphate accelerates wound healing in diabetic mice. J. Dermatol. Sci. 48,53–60.CrossRefGoogle ScholarPubMed
et al. (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig. Dis. Sci. 53, 997–1012.CrossRefGoogle ScholarPubMed
et al. (2008) Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L1085–93.CrossRefGoogle ScholarPubMed
et al. (2008) Anti-inflammatory effects of spohingosine kinase moudulation in inflammatory arthritis. J. Immunol. 1, 8010–8017.CrossRefGoogle Scholar
et al. (2009) A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 23, 143–152.CrossRefGoogle ScholarPubMed
et al. (2009) Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp. Eye Res. 88, 367–377.CrossRefGoogle Scholar
et al. (2009) Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. J. Cell. Physiol. 218, 192–198.CrossRefGoogle ScholarPubMed